Showing results (991-1000 of 3,351) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|April 7, 1996
Pharmacoeconomic analysis of stress ulcer prophylaxis for critically ill patientsG T Schumock, N P Lam, S R Winkler, et al.Pharmacoeconomics|June 6, 1996
Colony-stimulating factors and peripheral blood progenitor cell transplantation. Benefits and costsC A Uyl-de Groot, P C Huijgens, F F RuttenPharmacoeconomics|June 6, 1996
Comparing dihydroergotamine mesylate and sumatriptan in the management of acute migraine. A retrospective cost-efficacy analysisK Payne, C M Kozma, B J LawrencePharmacoeconomics|June 6, 1996
Pharmacoeconomics of Pneumocystis carinii pneumonia in HIV-infected and HIV-noninfected patientsD P Nicolau, J W Ross, R Quintiliani, et al.Pharmacoeconomics|June 6, 1996
Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillinA M Craig, P Davey, M Malek, et al.Pharmacoeconomics|June 6, 1996
Cost effectiveness and the allocation of therapies in a treating populationP C LangleyPharmacoeconomics|May 7, 1996
Is there scope for improving the cost-effective prescribing of nonsteroidal anti-inflammatory drugs?K Bloor, A MaynardPharmacoeconomics|May 7, 1996
Clinical and cost considerations in the pharmacotherapy of vulvovaginal candidiasisI W FongPharmacoeconomics|May 7, 1996
Estimating the cost effectiveness of atovaquone versus intravenous pentamidine in the treatment of mild-to-moderate Pneumocystis carinii pneumoniaG A Zarkin, M V Bala, L L Wood, et al.Pageof 336